Analysts: Synta Pharmaceuticals Corp (SNTA.OQ)

SNTA.OQ on NASDAQ Stock Exchange Global Market

3.67USD
16 Sep 2014
Price Change (% chg)

$-0.22 (-5.66%)
Prev Close
$3.89
Open
$3.87
Day's High
$3.89
Day's Low
$3.66
Volume
1,413,491
Avg. Vol
444,907
52-wk High
$7.22
52-wk Low
$3.66

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -0.24 December 17 Sep 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 2
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 1 1 1 1
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.80 2.80 2.80 2.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 6 0.45 2.60 0.00 --
Quarter Ending Dec-14 6 0.45 2.60 0.00 --
Year Ending Dec-14 5 1.09 5.20 0.00 8.75
Year Ending Dec-15 5 1.88 9.40 0.00 42.46
Earnings (per share)
Quarter Ending Sep-14 6 -0.24 -0.22 -0.27 --
Quarter Ending Dec-14 6 -0.24 -0.21 -0.27 --
Year Ending Dec-14 7 -1.02 -0.93 -1.20 -1.17
Year Ending Dec-15 6 -1.00 -0.80 -1.27 -1.10

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-14 0.43 0.00 0.43 100.00
Quarter Ending Mar-14 0.45 0.00 0.45 100.00
Quarter Ending Dec-13 0.37 0.00 0.37 100.00
Quarter Ending Sep-13 0.00 0.00 0.00 0.00
Quarter Ending Jun-13 0.32 0.00 0.32 100.00
Earnings (per share)
Quarter Ending Jun-14 -0.27 -0.24 0.03 -10.01
Quarter Ending Mar-14 -0.29 -0.28 0.01 -2.34
Quarter Ending Dec-13 -0.30 -0.31 0.01 -3.33
Quarter Ending Sep-13 -0.31 -0.33 0.02 -7.74
Quarter Ending Jun-13 -0.29 -0.33 0.04 -11.86

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 0.45 0.45 0.45 0.45 --
Quarter Ending Dec-14 0.45 0.45 0.45 0.45 --
Year Ending Dec-14 1.09 1.09 1.63 1.63 8.75
Year Ending Dec-15 1.88 1.88 1.88 1.75 42.46
Earnings (per share)
Quarter Ending Sep-14 -0.24 -0.24 -0.24 -0.27 --
Quarter Ending Dec-14 -0.24 -0.24 -0.24 -0.27 --
Year Ending Dec-14 -1.02 -1.02 -1.02 -1.09 -1.17
Year Ending Dec-15 -1.00 -1.00 -1.00 -1.11 -1.10

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-14 0 0 0 0
Quarter Ending Dec-14 0 0 0 0
Year Ending Dec-14 0 0 0 1
Year Ending Dec-15 0 0 0 0
Earnings
Quarter Ending Sep-14 0 0 0 0
Quarter Ending Dec-14 0 0 0 0
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 0 0 0

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks